Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
COVID-19 mRNA vaccine immunogenicity decay and breakthrough illness in adolescents and young adults with childhood-onset rheumatic diseases.
Yeo JG, Teh KL, Chia WN, Book YX, Hoh SF, Gao X, Das L, Zhang J, Sutamam N, Poh SL, Lim AJM, Tay SH, Yaung KN, Ong XM, Leong JY, Wang LF, Albani S, Arkachaisri T. Yeo JG, et al. Among authors: chia wn. Rheumatology (Oxford). 2023 Sep 1;62(9):3101-3109. doi: 10.1093/rheumatology/kead031. Rheumatology (Oxford). 2023. PMID: 36661304
Bat ASC2 suppresses inflammasomes and ameliorates inflammatory diseases.
Ahn M, Chen VC, Rozario P, Ng WL, Kong PS, Sia WR, Kang AEZ, Su Q, Nguyen LH, Zhu F, Chan WOY, Tan CW, Cheong WS, Hey YY, Foo R, Guo F, Lim YT, Li X, Chia WN, Sobota RM, Fu NY, Irving AT, Wang LF. Ahn M, et al. Among authors: chia wn. Cell. 2023 May 11;186(10):2144-2159.e22. doi: 10.1016/j.cell.2023.03.036. Cell. 2023. PMID: 37172565 Free article.
Immunogenicity of mRNA vs. BBV152 vaccine boosters against Omicron subvariants: Final results from Phase B of the PRIBIVAC study, a randomized clinical trial.
Poh XY, Torres-Ruesta A, Yoong T, Wong N, Tan CW, Rouers A, Chavatte JM, Goh YS, Rao S, Chia PY, Ong SWX, Lee TH, Sadarangani SP, Lin RJH, Neo V, Kam IKJ, Huang Y, Hor PX, Loh CY; PRIBIVAC study group; Yeoh AY, Lim DRX, Chia W, Ren EC, Lin RTP, Fong SW, Renia L, Lye DC, Wang LF, Ng LFP, Young BE. Poh XY, et al. Vaccine. 2024 Nov 14;42(25):126275. doi: 10.1016/j.vaccine.2024.126275. Epub 2024 Sep 5. Vaccine. 2024. PMID: 39241318 Free article. Clinical Trial.
Discrepant serological findings in SARS-CoV-2 PCR-negative hospitalized patients with fever and acute respiratory symptoms during the pandemic.
Cross GB, Naftalin CM, Ngiam JN, Bagdasarian N, Poh CM, Goh YS, Chia WN, Amrun SN, Tham SM, Teng H, Alagha R, Kumar SK, Tan SSY, Wang LF, Tambyah PA, Renia L, Fisher D, Ng LFP. Cross GB, et al. Among authors: chia wn. J Med Virol. 2022 Jun;94(6):2460-2470. doi: 10.1002/jmv.27656. Epub 2022 Mar 12. J Med Virol. 2022. PMID: 35171507 Free PMC article.
Genomic Characterization of a Relative of Mumps Virus in Lesser Dawn Bats of Southeast Asia.
Paskey AC, Lim XF, Ng JHJ, Rice GK, Chia WN, Philipson CW, Foo R, Cer RZ, Long KA, Lueder MR, Glang L, Frey KG, Hamilton T, Mendenhall IH, Smith GJ, Anderson DE, Wang LF, Bishop-Lilly KA. Paskey AC, et al. Among authors: chia wn. Viruses. 2023 Feb 28;15(3):659. doi: 10.3390/v15030659. Viruses. 2023. PMID: 36992368 Free PMC article.
First SARS-CoV-2 Omicron infection as an effective immune booster among mRNA vaccinated individuals: final results from the first phase of the PRIBIVAC randomised clinical trial.
Poh XY, Lee IR, Tan CW, Chavatte JM, Fong SW, Goh YS, Rouers A, Wong N, Torres-Ruesta A, Mah SYY, Yeoh AYY, Gandhi M, Rahman N, Chin YQ, Lim JJ, Yoong TJK, Rao S, Chia PY, Ong SWX, Lee TH, Sadarangani SP, Lin RJH, Lim DRX, Chia W, Renia L, Ren EC, Lin RTP, Lye DC, Wang LF, Ng LFP, Young BE. Poh XY, et al. EBioMedicine. 2024 Sep;107:105275. doi: 10.1016/j.ebiom.2024.105275. Epub 2024 Aug 12. EBioMedicine. 2024. PMID: 39137572 Free PMC article. Clinical Trial.
79 results